{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T03:32:20Z","timestamp":1794799940831,"version":"4.9.1"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,19]],"date-time":"2021-01-19T00:00:00Z","timestamp":1611014400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,1,19]],"date-time":"2021-01-19T00:00:00Z","timestamp":1611014400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000057","name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R35GM119438"],"award-info":[{"award-number":["R35GM119438"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"name":"North Carolina State University College of Veterinary Medicine intramural award"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    <jats:italic>Clostridioides difficile<\/jats:italic>\n                    is a bacterial pathogen that causes a range of clinical disease from mild to moderate diarrhea, pseudomembranous colitis, and toxic megacolon. Typically,\n                    <jats:italic>C. difficile<\/jats:italic>\n                    infections (CDIs) occur after antibiotic treatment, which alters the gut microbiota, decreasing colonization resistance against\n                    <jats:italic>C. difficile<\/jats:italic>\n                    . Disease is mediated by two large toxins and the expression of their genes is induced upon nutrient depletion via the alternative sigma factor TcdR. Here, we use tcdR mutants in two strains of\n                    <jats:italic>C. difficile<\/jats:italic>\n                    and omics to investigate how toxin-induced inflammation alters\n                    <jats:italic>C. difficile<\/jats:italic>\n                    metabolism, tissue gene expression and the gut microbiota, and to determine how inflammation by the host may be beneficial to\n                    <jats:italic>C. difficile<\/jats:italic>\n                    . We show that\n                    <jats:italic>C. difficile<\/jats:italic>\n                    metabolism is significantly different in the face of inflammation, with changes in many carbohydrate and amino acid uptake and utilization pathways. Host gene expression signatures suggest that degradation of collagen and other components of the extracellular matrix by matrix metalloproteinases is a major source of peptides and amino acids that supports\n                    <jats:italic>C. difficile<\/jats:italic>\n                    growth in vivo. Lastly, the inflammation induced by\n                    <jats:italic>C. difficile<\/jats:italic>\n                    toxin activity alters the gut microbiota, excluding members from the genus\n                    <jats:italic>Bacteroides<\/jats:italic>\n                    that are able to utilize the same essential nutrients released from collagen degradation.\n                  <\/jats:p>","DOI":"10.1038\/s41467-020-20746-4","type":"journal-article","created":{"date-parts":[[2021,1,19]],"date-time":"2021-01-19T06:09:05Z","timestamp":1611036545000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":198,"title":["Clostridioides difficile exploits toxin-mediated inflammation to alter the host nutritional landscape and exclude competitors from the gut microbiota"],"prefix":"10.1038","volume":"12","author":[{"given":"Joshua R.","family":"Fletcher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5409-2700","authenticated-orcid":false,"given":"Colleen M.","family":"Pike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2630-2344","authenticated-orcid":false,"given":"Ruth J.","family":"Parsons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alissa J.","family":"Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew H.","family":"Foley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1575-473X","authenticated-orcid":false,"given":"Michael R.","family":"McLaren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8012-5302","authenticated-orcid":false,"given":"Stephanie A.","family":"Montgomery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1895-8941","authenticated-orcid":false,"given":"Casey M.","family":"Theriot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,19]]},"reference":[{"key":"20746_CR1","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1056\/NEJMoa1408913","volume":"372","author":"FC Lessa","year":"2015","unstructured":"Lessa, F. C., Winston, L. G. & McDonald, L. C., Emerging Infections Program C. difficile Surveillance Team. Burden of Clostridium difficile infection in the United States. N. Engl. J. Med. 372, 2369\u20132370 (2015).","journal-title":"N. Engl. J. Med."},{"key":"20746_CR2","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1146\/annurev-micro-090816-093458","volume":"71","author":"K Aktories","year":"2017","unstructured":"Aktories, K., Schwan, C. & Jank, T. Clostridium difficile toxin biology. Annu. Rev. Microbiol. 71, 281\u2013307 (2017).","journal-title":"Annu. Rev. Microbiol."},{"key":"20746_CR3","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/nature09415","volume":"467","author":"SE Winter","year":"2010","unstructured":"Winter, S. E. et al. Gut inflammation provides a respiratory electron acceptor for Salmonella. Nature 467, 426\u2013429 (2010).","journal-title":"Nature"},{"key":"20746_CR4","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.chom.2017.11.006","volume":"23","author":"CC Gillis","year":"2018","unstructured":"Gillis, C. C. et al. Dysbiosis-associated change in host metabolism generates lactate to support salmonella growth. Cell Host Microbe 23, 54\u201364.e6 (2018).","journal-title":"Cell Host Microbe"},{"key":"20746_CR5","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/s41586-019-1453-3","volume":"572","author":"F Rivera-Ch\u00e1vez","year":"2019","unstructured":"Rivera-Ch\u00e1vez, F. & Mekalanos, J. J. Cholera toxin promotes pathogen acquisition of host-derived nutrients. Nature 572, 244\u2013248 (2019).","journal-title":"Nature"},{"key":"20746_CR6","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1080\/10409238.2016.1199535","volume":"51","author":"M de Bruyn","year":"2016","unstructured":"de Bruyn, M. et al. The molecular biology of matrix metalloproteinases and tissue inhibitors of metalloproteinases in inflammatory bowel diseases. Crit. Rev. Biochem. Mol. Biol. 51, 295\u2013358 (2016).","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"20746_CR7","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1111\/j.1365-2036.2011.04661.x","volume":"33","author":"M-H Jen","year":"2011","unstructured":"Jen, M.-H., Saxena, S., Bottle, A., Aylin, P. & Pollok, R. C. G. Increased health burden associated with Clostridium difficile diarrhoea in patients with inflammatory bowel disease. Aliment. Pharmacol. Ther. 33, 1322\u20131331 (2011).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"20746_CR8","first-page":"615","volume":"8","author":"DG Binion","year":"2012","unstructured":"Binion, D. G. Clostridium difficile Infection in patients with inflammatory bowel disease. Gastroenterol. Hepatol. 8, 615\u2013617 (2012).","journal-title":"Gastroenterol. Hepatol."},{"key":"20746_CR9","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1111\/apt.12073","volume":"36","author":"SK Murthy","year":"2012","unstructured":"Murthy, S. K. et al. Impact of Clostridium difficile colitis on 5-year health outcomes in patients with ulcerative colitis. Aliment. Pharmacol. Ther. 36, 1032\u20131039 (2012).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"20746_CR10","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.cgh.2006.12.027","volume":"5","author":"JF Rodemann","year":"2007","unstructured":"Rodemann, J. F., Dubberke, E. R., Reske, K. A., Seo, D. H. & Stone, C. D. Incidence of Clostridium difficile infection in inflammatory bowel disease. Clin. Gastroenterol. Hepatol. 5, 339\u2013344 (2007).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"20746_CR11","doi-asserted-by":"crossref","unstructured":"Fletcher, J. R., Erwin, S., Lanzas, C. & Theriot, C. M. Shifts in the gut metabolome and Clostridium difficile transcriptome throughout colonization and infection in a mouse model. mSphere 3, e00089 (2018).","DOI":"10.1128\/mSphere.00089-18"},{"issue":"Pt 2","key":"20746_CR12","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1099\/13500872-141-2-371","volume":"141","author":"T Karasawa","year":"1995","unstructured":"Karasawa, T., Ikoma, S., Yamakawa, K. & Nakamura, S. A defined growth medium for Clostridium difficile. Microbiol. Read. Engl. 141(Pt 2), 371\u2013375 (1995).","journal-title":"Microbiol. Read. Engl."},{"key":"20746_CR13","doi-asserted-by":"publisher","first-page":"8487","DOI":"10.1128\/JB.01370-06","volume":"188","author":"S Jackson","year":"2006","unstructured":"Jackson, S., Calos, M., Myers, A. & Self, W. T. Analysis of proline reduction in the nosocomial pathogen Clostridium difficile. J. Bacteriol. 188, 8487\u20138495 (2006).","journal-title":"J. Bacteriol."},{"key":"20746_CR14","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1128\/JB.01492-12","volume":"195","author":"L Bouillaut","year":"2013","unstructured":"Bouillaut, L., Self, W. T. & Sonenshein, A. L. Proline-dependent regulation of Clostridium difficile Stickland metabolism. J. Bacteriol. 195, 844\u2013854 (2013).","journal-title":"J. Bacteriol."},{"key":"20746_CR15","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.3389\/fmicb.2018.01970","volume":"9","author":"JD Hofmann","year":"2018","unstructured":"Hofmann, J. D. et al. Metabolic reprogramming of Clostridioides difficile during the stationary phase with the induction of toxin production. Front. Microbiol. 9, 1970 (2018).","journal-title":"Front. Microbiol."},{"key":"20746_CR16","doi-asserted-by":"publisher","first-page":"e56051","DOI":"10.1371\/journal.pone.0056051","volume":"8","author":"YK Ng","year":"2013","unstructured":"Ng, Y. K. et al. Expanding the repertoire of gene tools for precise manipulation of the Clostridium difficile genome: allelic exchange using pyrE alleles. PloS ONE 8, e56051 (2013).","journal-title":"PloS ONE"},{"key":"20746_CR17","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/978-1-4939-6361-4_9","volume":"1476","author":"AN Edwards","year":"2016","unstructured":"Edwards, A. N. & McBride, S. M. Isolating and purifying Clostridium difficile spores. Methods Mol. Biol. Clifton NJ 1476, 117\u2013128 (2016).","journal-title":"Methods Mol. Biol. Clifton NJ"},{"key":"20746_CR18","doi-asserted-by":"publisher","first-page":"326","DOI":"10.4161\/gmic.19142","volume":"2","author":"CM Theriot","year":"2011","unstructured":"Theriot, C. M. et al. Cefoperazone-treated mice as an experimental platform to assess differential virulence of Clostridium difficile strains. Gut Microbes 2, 326\u2013334 (2011).","journal-title":"Gut Microbes"},{"key":"20746_CR19","doi-asserted-by":"crossref","unstructured":"Winston, J. A., Thanissery, R., Montgomery, S. A. & Theriot, C. M. Cefoperazone-treated mouse model of clinically-relevant Clostridium difficile Strain R20291. J. Vis. Exp. JoVE 118, 54850 (2016).","DOI":"10.3791\/54850"},{"key":"20746_CR20","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1093\/bioinformatics\/bts199","volume":"28","author":"M Kearse","year":"2012","unstructured":"Kearse, M. et al. Geneious Basic: an integrated and extendable desktop software platform for the organization and analysis of sequence data. Bioinformatics 28, 1647\u20131649 (2012).","journal-title":"Bioinformatics"},{"key":"20746_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"20746_CR22","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/nbt1385","volume":"26","author":"GK Geiss","year":"2008","unstructured":"Geiss, G. K. et al. Direct multiplexed measurement of gene expression with color-coded probe pairs. Nat. Biotechnol. 26, 317\u2013325 (2008).","journal-title":"Nat. Biotechnol."},{"key":"20746_CR23","unstructured":"Blighe, K., Rana, S. & Lewis, M. EnhancedVolcano: publication-ready volcano plots with enhanced colouring and labeling. https:\/\/github.com\/kevinblighe\/EnhancedVolcano."},{"key":"20746_CR24","unstructured":"Holdeman, L. V., Cato, E. D. & Moore, W. E. C. Anaerobe Laboratory Manual (Virginia Polytechnic Institute and State University Anaerobe Laboratory, 1977)."},{"key":"20746_CR25","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.chom.2008.09.007","volume":"4","author":"EC Martens","year":"2008","unstructured":"Martens, E. C., Chiang, H. C. & Gordon, J. I. Mucosal glycan foraging enhances fitness and transmission of a saccharolytic human gut bacterial symbiont. Cell Host Microbe 4, 447\u2013457 (2008).","journal-title":"Cell Host Microbe"},{"key":"20746_CR26","doi-asserted-by":"publisher","first-page":"5112","DOI":"10.1128\/AEM.01043-13","volume":"79","author":"JJ Kozich","year":"2013","unstructured":"Kozich, J. J., Westcott, S. L., Baxter, N. T., Highlander, S. K. & Schloss, P. D. Development of a dual-index sequencing strategy and curation pipeline for analyzing amplicon sequence data on the MiSeq Illumina sequencing platform. Appl. Environ. Microbiol. 79, 5112\u20135120 (2013).","journal-title":"Appl. Environ. Microbiol."},{"key":"20746_CR27","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1038\/s41587-019-0209-9","volume":"37","author":"E Bolyen","year":"2019","unstructured":"Bolyen, E. et al. Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2. Nat. Biotechnol. 37, 852\u2013857 (2019).","journal-title":"Nat. Biotechnol."},{"key":"20746_CR28","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nmeth.3869","volume":"13","author":"BJ Callahan","year":"2016","unstructured":"Callahan, B. J. et al. DADA2: High-resolution sample inference from Illumina amplicon data. Nat. Methods 13, 581\u2013583 (2016).","journal-title":"Nat. Methods"},{"key":"20746_CR29","doi-asserted-by":"publisher","first-page":"D643","DOI":"10.1093\/nar\/gkt1209","volume":"42","author":"P Yilmaz","year":"2014","unstructured":"Yilmaz, P. et al. The SILVA and \u2018All-species Living Tree Project (LTP)\u2019 taxonomic frameworks. Nucleic Acids Res. 42, D643\u2013D648 (2014).","journal-title":"Nucleic Acids Res."},{"key":"20746_CR30","doi-asserted-by":"publisher","unstructured":"Thanissery, R. et al. Characterization of C. difficile strains isolated from companion animals and the associated changes in the host fecal microbiota. bioRxiv https:\/\/doi.org\/10.1101\/822577 (2019).","DOI":"10.1101\/822577"},{"key":"20746_CR31","doi-asserted-by":"publisher","unstructured":"Legendre, P. & Gallagher, E. Ecologically meaningful transformations for ordination of species data. Oecologia 271\u2013280, https:\/\/doi.org\/10.1007\/s004420100716 (2001).","DOI":"10.1007\/s004420100716"},{"key":"20746_CR32","doi-asserted-by":"publisher","first-page":"e61217","DOI":"10.1371\/journal.pone.0061217","volume":"8","author":"PJ McMurdie","year":"2013","unstructured":"McMurdie, P. J. & Holmes, S. phyloseq: an R package for reproducible interactive analysis and graphics of microbiome census data. PloS ONE 8, e61217 (2013).","journal-title":"PloS ONE"},{"key":"20746_CR33","unstructured":"McMurdie, P. J. & Paulson, J. N. biomformat: An interface package for the BIOM file format. https:\/\/github.com\/joey711\/biomformat\/, http:\/\/biom-format.org\/ (2020)."},{"key":"20746_CR34","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1111\/mmi.14107","volume":"110","author":"EM Ransom","year":"2018","unstructured":"Ransom, E. M., Kaus, G. M., Tran, P. M., Ellermeier, C. D. & Weiss, D. S. Multiple factors contribute to bimodal toxin gene expression in Clostridioides (Clostridium) difficile. Mol. Microbiol. 110, 533\u2013549 (2018).","journal-title":"Mol. Microbiol."},{"key":"20746_CR35","doi-asserted-by":"crossref","unstructured":"Girinathan, B. P. et al. Effect of tcdR mutation on sporulation in the epidemic Clostridium difficile Strain R20291. mSphere 2, e00383 (2017).","DOI":"10.1128\/mSphere.00383-16"},{"key":"20746_CR36","doi-asserted-by":"crossref","unstructured":"Jenior, M. L., Leslie, J. L., Young, V. B. & Schloss, P. D. Clostridium difficile colonizes alternative nutrient niches during infection across distinct murine gut microbiomes. mSystems 2, e00063 (2017).","DOI":"10.1128\/mSystems.00063-17"},{"key":"20746_CR37","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1128\/MMBR.00024-06","volume":"70","author":"J Deutscher","year":"2006","unstructured":"Deutscher, J., Francke, C. & Postma, P. W. How phosphotransferase system-related protein phosphorylation regulates carbohydrate metabolism in bacteria. Microbiol. Mol. Biol. Rev. MMBR 70, 939\u20131031 (2006).","journal-title":"Microbiol. Mol. Biol. Rev. MMBR"},{"key":"20746_CR38","doi-asserted-by":"publisher","first-page":"6357","DOI":"10.1128\/JB.00937-10","volume":"192","author":"SR Brinsmade","year":"2010","unstructured":"Brinsmade, S. R., Kleijn, R. J., Sauer, U. & Sonenshein, A. L. Regulation of CodY activity through modulation of intracellular branched-chain amino acid pools. J. Bacteriol. 192, 6357\u20136368 (2010).","journal-title":"J. Bacteriol."},{"key":"20746_CR39","doi-asserted-by":"publisher","first-page":"5350","DOI":"10.1128\/JB.00341-10","volume":"192","author":"SS Dineen","year":"2010","unstructured":"Dineen, S. S., McBride, S. M. & Sonenshein, A. L. Integration of metabolism and virulence by Clostridium difficile CodY. J. Bacteriol. 192, 5350\u20135362 (2010).","journal-title":"J. Bacteriol."},{"key":"20746_CR40","doi-asserted-by":"publisher","first-page":"4581","DOI":"10.1021\/cr0101757","volume":"102","author":"WT Lowther","year":"2002","unstructured":"Lowther, W. T. & Matthews, B. W. Metalloaminopeptidases: common functional themes in disparate structural surroundings. Chem. Rev. 102, 4581\u20134608 (2002).","journal-title":"Chem. Rev."},{"key":"20746_CR41","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/j.1365-2672.2012.05310.x","volume":"113","author":"RL Kitchener","year":"2012","unstructured":"Kitchener, R. L. & Grunden, A. M. Prolidase function in proline metabolism and its medical and biotechnological applications. J. Appl. Microbiol. 113, 233\u2013247 (2012).","journal-title":"J. Appl. Microbiol."},{"key":"20746_CR42","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1046\/j.1432-1327.2001.02001.x","volume":"268","author":"T Selmer","year":"2001","unstructured":"Selmer, T. & Andrei, P. I. p-Hydroxyphenylacetate decarboxylase from Clostridium difficile. A novel glycyl radical enzyme catalysing the formation of p-cresol. Eur. J. Biochem. 268, 1363\u20131372 (2001).","journal-title":"Eur. J. Biochem."},{"key":"20746_CR43","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/1471-2180-11-86","volume":"11","author":"LF Dawson","year":"2011","unstructured":"Dawson, L. F. et al. The analysis of para-cresol production and tolerance in Clostridium difficile 027 and 012 strains. BMC Microbiol. 11, 86 (2011).","journal-title":"BMC Microbiol."},{"key":"20746_CR44","doi-asserted-by":"publisher","first-page":"e1007191","DOI":"10.1371\/journal.ppat.1007191","volume":"14","author":"IJ Passmore","year":"2018","unstructured":"Passmore, I. J. et al. Para-cresol production by Clostridium difficile affects microbial diversity and membrane integrity of Gram-negative bacteria. PLoS Pathog. 14, e1007191 (2018).","journal-title":"PLoS Pathog."},{"key":"20746_CR45","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1128\/IAI.00731-10","volume":"79","author":"SM McBride","year":"2011","unstructured":"McBride, S. M. & Sonenshein, A. L. Identification of a genetic locus responsible for antimicrobial peptide resistance in Clostridium difficile. Infect. Immun. 79, 167\u2013176 (2011).","journal-title":"Infect. Immun."},{"key":"20746_CR46","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.1128\/JB.00166-13","volume":"195","author":"JM Su\u00e1rez","year":"2013","unstructured":"Su\u00e1rez, J. M., Edwards, A. N. & McBride, S. M. The Clostridium difficile cpr locus is regulated by a noncontiguous two-component system in response to type A and B lantibiotics. J. Bacteriol. 195, 2621\u20132631 (2013).","journal-title":"J. Bacteriol."},{"key":"20746_CR47","doi-asserted-by":"crossref","unstructured":"Jenior, M. L., Leslie, J. L., Young, V. B. & Schloss, P. D. Clostridium difficile alters the structure and metabolism of distinct cecal microbiomes during initial infection to promote sustained colonization. mSphere 3, e00261 (2018).","DOI":"10.1128\/mSphere.00261-18"},{"key":"20746_CR48","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1099\/00222615-41-5-319","volume":"41","author":"K Yamakawa","year":"1994","unstructured":"Yamakawa, K., Kamiya, S., Meng, X. Q., Karasawa, T. & Nakamura, S. Toxin production by Clostridium difficile in a defined medium with limited amino acids. J. Med. Microbiol. 41, 319\u2013323 (1994).","journal-title":"J. Med. Microbiol."},{"key":"20746_CR49","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1186\/s12866-015-0614-2","volume":"15","author":"M Neumann-Schaal","year":"2015","unstructured":"Neumann-Schaal, M., Hofmann, J. D., Will, S. E. & Schomburg, D. Time-resolved amino acid uptake of Clostridium difficile 630\u0394erm and concomitant fermentation product and toxin formation. BMC Microbiol. 15, 281 (2015).","journal-title":"BMC Microbiol."},{"key":"20746_CR50","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.ijmm.2017.05.007","volume":"307","author":"T Riedel","year":"2017","unstructured":"Riedel, T. et al. High metabolic versatility of different toxigenic and non-toxigenic Clostridioides difficile isolates. Int. J. Med. Microbiol. IJMM 307, 311\u2013320 (2017).","journal-title":"Int. J. Med. Microbiol. IJMM"},{"key":"20746_CR51","doi-asserted-by":"crossref","unstructured":"Battaglioli, E. J. et al. Clostridioides difficile uses amino acids associated with gut microbial dysbiosis in a subset of patients with diarrhea. Sci. Transl. Med. 10, eaam7019 (2018).","DOI":"10.1126\/scitranslmed.aam7019"},{"key":"20746_CR52","first-page":"437","volume":"9","author":"YY Huang","year":"2018","unstructured":"Huang, Y. Y., Mart\u00ednez-Del Campo, A. & Balskus, E. P. Anaerobic 4-hydroxyproline utilization: discovery of a new glycyl radical enzyme in the human gut microbiome uncovers a widespread microbial metabolic activity. Gut Microbes 9, 437\u2013451 (2018).","journal-title":"Gut Microbes"},{"key":"20746_CR53","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1093\/cid\/ciy149","volume":"66","author":"LC McDonald","year":"2018","unstructured":"McDonald, L. C. et al. Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin. Infect. Dis. 66, 987\u2013994 (2018).","journal-title":"Clin. Infect. Dis."},{"key":"20746_CR54","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.anaerobe.2017.01.009","volume":"44","author":"TW Bilverstone","year":"2017","unstructured":"Bilverstone, T. W., Kinsmore, N. L., Minton, N. P. & Kuehne, S. A. Development of Clostridium difficile R20291\u0394PaLoc model strains and in vitro methodologies reveals CdtR is required for the production of CDT to cytotoxic levels. Anaerobe 44, 51\u201354 (2017).","journal-title":"Anaerobe"},{"key":"20746_CR55","doi-asserted-by":"publisher","first-page":"16108","DOI":"10.1038\/nmicrobiol.2016.108","volume":"1","author":"CA Cowardin","year":"2016","unstructured":"Cowardin, C. A. et al. The binary toxin CDT enhances Clostridium difficile virulence by suppressing protective colonic eosinophilia. Nat. Microbiol. 1, 16108 (2016).","journal-title":"Nat. Microbiol."},{"key":"20746_CR56","doi-asserted-by":"publisher","first-page":"e1006701","DOI":"10.1371\/journal.pgen.1006701","volume":"13","author":"BR Anjuwon-Foster","year":"2017","unstructured":"Anjuwon-Foster, B. R. & Tamayo, R. A genetic switch controls the production of flagella and toxins in Clostridium difficile. PLoS Genet. 13, e1006701 (2017).","journal-title":"PLoS Genet."},{"key":"20746_CR57","doi-asserted-by":"crossref","unstructured":"Levin, B. J. et al. A prominent glycyl radical enzyme in human gut microbiomes metabolizes trans-4-hydroxy-l-proline. Science 355, eaai8386 (2017).","DOI":"10.1126\/science.aai8386"},{"key":"20746_CR58","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1006\/bbrc.2000.3630","volume":"277","author":"T Koike","year":"2000","unstructured":"Koike, T. et al. Activation of MMP-2 by Clostridium difficile toxin B in bovine smooth muscle cells. Biochem. Biophys. Res. Commun. 277, 43\u201346 (2000).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"20746_CR59","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1093\/ibd\/izx059","volume":"24","author":"F Zhou","year":"2018","unstructured":"Zhou, F. et al. Mice with inflammatory bowel disease are susceptible to Clostridium difficile infection with severe disease outcomes. Inflamm. Bowel Dis. 24, 573\u2013582 (2018).","journal-title":"Inflamm. Bowel Dis."},{"key":"20746_CR60","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/j.chom.2019.03.003","volume":"25","author":"MM Saleh","year":"2019","unstructured":"Saleh, M. M. et al. Colitis-induced Th17 cells increase the risk for severe subsequent Clostridium difficile infection. Cell Host Microbe 25, 756\u2013765.e5 (2019).","journal-title":"Cell Host Microbe"},{"key":"20746_CR61","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1128\/IAI.01432-07","volume":"76","author":"M Barman","year":"2008","unstructured":"Barman, M. et al. Enteric salmonellosis disrupts the microbial ecology of the murine gastrointestinal tract. Infect. Immun. 76, 907\u2013915 (2008).","journal-title":"Infect. Immun."},{"key":"20746_CR62","doi-asserted-by":"publisher","first-page":"30","DOI":"10.4161\/gmic.1.1.10950","volume":"1","author":"I Sekirov","year":"2010","unstructured":"Sekirov, I. et al. Salmonella SPI-1-mediated neutrophil recruitment during enteric colitis is associated with reduction and alteration in intestinal microbiota. Gut Microbes 1, 30\u201341 (2010).","journal-title":"Gut Microbes"},{"key":"20746_CR63","doi-asserted-by":"publisher","first-page":"7527","DOI":"10.1073\/pnas.0914322107","volume":"107","author":"M He","year":"2010","unstructured":"He, M. et al. Evolutionary dynamics of Clostridium difficile over short and long time scales. Proc. Natl Acad. Sci. U. S. A. 107, 7527\u20137532 (2010).","journal-title":"Proc. Natl Acad. Sci. U. S. A."},{"key":"20746_CR64","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1016\/S0140-6736(89)92749-9","volume":"1","author":"M Tvede","year":"1989","unstructured":"Tvede, M. & Rask-Madsen, J. Bacteriotherapy for chronic relapsing Clostridium difficile diarrhoea in six patients. Lancet Lond. Engl. 1, 1156\u20131160 (1989).","journal-title":"Lancet Lond. Engl."},{"key":"20746_CR65","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s10096-013-1966-x","volume":"33","author":"E Goldberg","year":"2014","unstructured":"Goldberg, E. et al. The correlation between Clostridium-difficile infection and human gut concentrations of Bacteroidetes phylum and clostridial species. Eur. J. Clin. Microbiol. Infect. Dis. 33, 377\u2013383 (2014).","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"20746_CR66","doi-asserted-by":"publisher","first-page":"879","DOI":"10.3389\/fmicb.2019.00879","volume":"10","author":"BO Anonye","year":"2019","unstructured":"Anonye, B. O. et al. Probing Clostridium difficile infection in complex human gut cellular models. Front. Microbiol. 10, 879 (2019).","journal-title":"Front. Microbiol."},{"key":"20746_CR67","doi-asserted-by":"publisher","first-page":"2976","DOI":"10.3389\/fmicb.2018.02976","volume":"9","author":"H Deng","year":"2018","unstructured":"Deng, H. et al. Bacteroides fragilis prevents Clostridium difficile infection in a mouse model by restoring gut barrier and microbiome regulation. Front. Microbiol. 9, 2976 (2018).","journal-title":"Front. Microbiol."},{"key":"20746_CR68","doi-asserted-by":"crossref","unstructured":"Ghimire, S. et al. Identification of Clostridioides difficile-inhibiting gut commensals using culturomics, phenotyping, and combinatorial community assembly. mSystems 5, e00620 (2020).","DOI":"10.1128\/mSystems.00620-19"},{"key":"20746_CR69","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.chom.2014.11.003","volume":"16","author":"JA Ferreyra","year":"2014","unstructured":"Ferreyra, J. A. et al. Gut microbiota-produced succinate promotes C. difficile infection after antibiotic treatment or motility disturbance. Cell Host Microbe 16, 770\u2013777 (2014).","journal-title":"Cell Host Microbe"},{"key":"20746_CR70","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18928-1","volume":"11","author":"FC Pereira","year":"2020","unstructured":"Pereira, F. C. et al. Rational design of a microbial consortium of mucosal sugar utilizers reduces Clostridiodes difficile colonization. Nat. Commun. 11, 5104 (2020).","journal-title":"Nat. Commun."},{"key":"20746_CR71","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/s41564-019-0658-4","volume":"5","author":"RA Oliveira","year":"2020","unstructured":"Oliveira, R. A. et al. Klebsiella michiganensis transmission enhances resistance to Enterobacteriaceae gut invasion by nutrition competition. Nat. Microbiol. 5, 630\u2013641 (2020).","journal-title":"Nat. Microbiol."},{"key":"20746_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2020.06.018","author":"G Caballero-Flores","year":"2020","unstructured":"Caballero-Flores, G., Pickard, J. M., Fukuda, S., Inohara, N. & N\u00fa\u00f1ez, G. An enteric pathogen subverts colonization resistance by evading competition for amino acids in the gut. Cell Host Microbe https:\/\/doi.org\/10.1016\/j.chom.2020.06.018 (2020).","journal-title":"Cell Host Microbe"},{"key":"20746_CR73","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/s41564-019-0591-6","volume":"5","author":"S Kitamoto","year":"2020","unstructured":"Kitamoto, S. et al. Dietary L-serine confers a competitive fitness advantage to Enterobacteriaceae in the inflamed gut. Nat. Microbiol. 5, 116\u2013125 (2020).","journal-title":"Nat. Microbiol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-20746-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-20746-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-20746-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T05:26:05Z","timestamp":1669958765000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-20746-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,19]]},"references-count":73,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["20746"],"URL":"https:\/\/doi.org\/10.1038\/s41467-020-20746-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.08.06.238881","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,19]]},"assertion":[{"value":"22 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"C.M.T. consults for Vedanta Biosciences, Inc. and Summit Therapeutics.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"462"}}